You have searched for "Science"
Showing 1-10 of 10000
NEW YORK, Oct. 24 (Xinhua) -- The COVID-19 test positivity rates trended slightly higher on Friday in New York State, with the rate in the "micro-cluster" focus areas, where the pandemic has been the most severe, reaching 2.58 percent, compared with 2.31 percent one day earlier, Governor Andrew Cuomo tweeted on Saturday.
CHICAGO, Oct. 24 (Xinhua) -- A Northwestern University (NU) research team has discovered in a study of zebrafish that there is a very orderly relationship between when spinal inhibitory neurons are born, their participation in different speeds of movement and what part of a motor neuron they innervate.
NEW YORK, Oct. 24 (Xinhua) -- American Crisis: Leadership Lessons from the COVID-19 Pandemic, the latest book by New York State Governor Andrew Cuomo published in mid-October, is listed on the No. 1 Best Seller in the category of Sociological Study of Medicine on Amazon.
PETALING JAYA: The Opposition should stop sowing instability and Datuk Seri Anwar Ibrahim should not be obsessed with wanting to become the next prime minister when the country was grappling with a health pandemic, says Datuk Seri Azmin Ali.
PUTRAJAYA: The government is expected to secure access to the Covid-19 vaccine in the first quarter of next year.
THE Higher Education Ministry suggested that by the end of 2020,15% of tertiary students will venture into entrepreneurship while still studying, with 5% aiming to become entrepreneurs upon graduating.
More factors need to be considered when designing spaces in the new normal.
Be reasonable, fight Covid-19 pandemic with rational, scientific, constitutional approach, says Tok Mat
PETALING JAYA: The Covid-19 pandemic should be tackled without undermining the Federal Constitution and functional democracy, says Datuk Seri Mohamad Hasan.
Covid-19 vaccine expected to be secured in first quarter next year; priority to be given to frontliners
PUTRAJAYA: The government is expected to secure access to Covid-19 vaccines in the first quarter of next year with priority given to frontliners, says the government.
MEXICO CITY (Reuters) - Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug remdesivir for use in COVID-19 patients, a top Mexican health official said on Friday.